Aguet M, Merlin G
J Exp Med. 1987 Apr 1;165(4):988-99. doi: 10.1084/jem.165.4.988.
mAbs against human IFN-gamma (huIFN-gamma) receptors were obtained by immunizing a BALB/c mouse with eluates from immobilized recombinant huIFN-gamma (rhuIFN-gamma) on which lysates of enriched Raji cell membranes had been adsorbed. mAbs were selected for competitive inhibition of receptor binding of 125I-labeled rhuIFN-gamma. The following additional properties suggest that these antibodies are specific for huIFN-gamma receptors: they bind to the surface of human cells expressing IFN-gamma receptors but not to heterologous cells; this binding is inhibited competitively by addition of rhuIFN-gamma; the number of binding sites revealed by direct binding of 125I-labeled rhuIFN-gamma correlates with the amount of antigen recognized by the mAbs on different cell lines. A Triton X-100 extract of a membrane-enriched fraction of human Raji cells was affinity purified with these mAbs and the eluates from such columns were further purified on immobilized rhuIFN-gamma. As revealed by SDS-PAGE, the final eluate contained two major protein bands with approximate Mr of 90,000 (p90) and 50,000 (p50), respectively. Both proteins were able to specifically bind 125I-labeled rhuIFN-gamma upon electroblotting to nitrocellulose. This binding could be inhibited by the huIFN-gamma receptor mAbs, suggesting that the same epitopes are recognized on p90, p50, and on the cell surface. Therefore, these proteins most likely represent at least a part of huIFN-gamma receptors.
通过用固定化重组人干扰素 -γ(rhuIFN -γ)的洗脱液免疫BALB/c小鼠获得抗人干扰素 -γ(huIFN -γ)受体的单克隆抗体,该固定化rhuIFN -γ吸附了富集的拉吉细胞膜裂解物。选择单克隆抗体用于竞争性抑制125I标记的rhuIFN -γ与受体的结合。以下其他特性表明这些抗体对huIFN -γ受体具有特异性:它们与表达IFN -γ受体的人细胞表面结合,但不与异源细胞结合;加入rhuIFN -γ可竞争性抑制这种结合;125I标记的rhuIFN -γ直接结合所揭示的结合位点数与不同细胞系上单克隆抗体识别的抗原量相关。用这些单克隆抗体对人拉吉细胞富含膜的部分的Triton X - 100提取物进行亲和纯化,并且将来自此类柱的洗脱液在固定化rhuIFN -γ上进一步纯化。如SDS - PAGE所示,最终洗脱液含有两条主要蛋白带,其表观分子量分别约为90,000(p90)和50,000(p50)。将这两种蛋白电印迹到硝酸纤维素膜上后,它们都能够特异性结合125I标记的rhuIFN -γ。这种结合可被huIFN -γ受体单克隆抗体抑制,表明在p90、p50和细胞表面识别相同的表位。因此,这些蛋白很可能至少代表huIFN -γ受体的一部分。